A Long term study of M071754 - A open-label study in patients with infantile spasms -
Latest Information Update: 04 Dec 2018
At a glance
- Drugs Vigabatrin (Primary)
- Indications Infantile spasms
- Focus Adverse reactions; Therapeutic Use
- Sponsors Alfresa Pharma Corporation
- 01 May 2017 Status changed from active, no longer recruiting to completed.
- 06 Jun 2016 New trial record